Canna Law Blog

NOVEMBER 27, 2021

DMT, like its sister psychedelics (LSD, MDMA, psilocybin … and even marijuana), is a Schedule I controlled substance. So according to the DEA, its abuse potential is high and it has no medical use. In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer.

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. The Drug Enforcement Agency (DEA) currently has guidance published for those interested in petitioning for a religious exemption to the CSA. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. We know such categorization is baseless and false. Rate this blog post.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Cannabis Law Report

APRIL 21, 2022

The availability of larger quantities of cGMP-compliant MDMA will facilitate ongoing clinical trials and provide for future therapeutic use following anticipated regulatory approvals. Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public .

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

APRIL 11, 2022

Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. Drug Enforcement Agency (DEA). The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Veriheal

JUNE 24, 2021

health official reportedly slammed “ongoing federal restrictions that are inhibiting research into marijuana”. The Senator stated that the NIH has been reporting on “potentially promising peer-reviewed clinical research” and asked for an update on how the NIH was planning to proceed and navigate issues. .

Research and Development 52

Research and Development Clinical Trials Treatment Access 52

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 352

Cultivation DEA Clinical Trials Marijuana 352

SpeedWeed

MARCH 25, 2021

A long-awaited clinical trial on using cannabis as a treatment for veterans with PTSD has finally been published in the PLOS One journal , but the results are far less promising than researchers and veterans had hoped. million grant from the Multidisciplinary Association of Psychedelic Studies (MAPS).

DEA 52

DEA Clinical Trials THC Pharmaceutical 52

SpeedWeed

MARCH 18, 2021

For years, many military veterans have used medical marijuana to manage the symptoms of PTSD. For Veterans With PTSD, Medical Marijuana Can Mean a Good Night’s Sleep. for the production of cannabis used in federally-regulated clinical trials. Wasn’t the DEA going to let others grow research-grade cannabis?

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Essay: “Trying Medical Marijuana, the Right Way”. Clinton Ransom . School: Miami University of Ohio.

Research and Development 117

Research and Development Education Agriculture Patients 117

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Veriheal

DECEMBER 21, 2022

President Joe Biden has officially signed a marijuana research bill into law. 8454, the “Medical Marijuana and Cannabidiol Research Expansion Act,” has been passed. attorney general 60 days to either approve a given application or request supplemental information from the marijuana research applicant. The law gives the U.S.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Cannabis Law Report

OCTOBER 20, 2021

Bank of America (BoA) is reportedly terminating its banking relationship with Scottsdale Research Institute (SRI), a DEA-registered facility that carries out important marijuana research. The quality of this cannabis had been criticised by a number of researchers, including Dr. Sisley.

Banking 52

Banking Clinical Trials DEA History 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Later that year, Doblin sued the DEA for the first time. Members of Congress voiced support for marijuana/AIDS research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

MAY 6, 2021

This compound is produced in very small amounts in marijuana and hemp, but most of what is on the market today is converted synthetically in a lab and sold in amounts largely unseen in nature. . If you have access to regulated cannabis that’s produced under acceptable standards, there’s no real reason to seek delta-8 products.

THC 145

THC Cannabinoids Concentrates Hemp 145

SpeedWeed

DECEMBER 28, 2018

As first reported by Leafly, Altria has “over the past five years quietly patented dozens of devices that could be used to consume marijuana, a review of public documents at the US Patent and Trademark Office shows.” Bummer: Patients Are Still Struggling for Cannabis Access. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Sisley just entered the national spotlight, known as the research doctor who’d been unfairly fired from the University of Arizona for simply trying to study medical marijuana.

DEA 230

DEA Research and Development Clinical Trials Patients 230

Cannabis Law Report

JANUARY 14, 2020

CLICK IMAGE TO ACCESS COMMITTEE INFO PAGE. 1151 , the “Veterans Medical Marijuana Safe Harbor Act” H.R. 2843 , the “Marijuana Freedom and Opportunity Act” H.R. 3797 , the “Medical Marijuana Research Act of 2019” H.R. 3884, Marijuana Opportunity Reinvestment and Expungement Act.

Clinical Trials 69

Clinical Trials Programs Access DEA 69